Investigating Neuroinflammation in Children with Ultra-Rare Genetic Mutations (DRAFT)
Dr. Herbert Lachman a leading researcher in neurogenomics at the Albert Einstein College of Medicine, is launching a new research project focused on understanding the role of neuroinflammation in children with ultra-rare genetic mutations. This project aims to uncover how chronic inflammation in the brain contributes to both neurological and behavioral symptoms, particularly in children who also exhibit traits of autism spectrum disorders.
By studying the immune response in the brains of these children, Dr. Lachman's team hopes to identify key inflammatory markers that could serve as targets for new therapies. Utilizing advanced neuroimaging and molecular techniques, the research will examine how inflammation may exacerbate or trigger the onset of symptoms such as sensory sensitivities, aggression, or communication difficulties.
The ultimate goal is to develop more effective anti-inflammatory treatments that could reduce the neurological impact of these rare genetic conditions, potentially improving the quality of life for affected children and their families. This research could lead to significant advances in understanding how inflammation and genetics interact to influence brain function, offering new hope for therapeutic interventions.
Follow the NRF24.ORG blog for updates on this exciting research and how it may transform care for children with rare genetic disorders.